Skip to main content
Erschienen in: Der Internist 10/2017

28.08.2017 | Typ-1-Diabetes | Schwerpunkt: Notfälle in der Endokrinologie/Diabetologie

Diabetologische Notfälle

Hypoglykämie, ketoazidotisches und hyperglykämisches Koma

verfasst von: Dr. med. H. Kalscheuer, G. Serfling, S. Schmid, H. Lehnert

Erschienen in: Die Innere Medizin | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die diabetologischen Notfälle Hypoglykämie, diabetische Ketoazidose (DKA) und hyperglykämische, hyperosmolare Entgleisung (HHE) sind potenziell lebensbedrohliche Komplikationen eines Diabetes mellitus und seiner Behandlung. Entsprechend erfordern sie eine rasche diagnostische und therapeutische Intervention. DKA und HHE zeichnen sich durch einen absoluten bzw. relativen Insulinmangel sowie durch eine schwere Dehydratation aus. Sie unterscheiden sich im Vorhandensein von Ketonkörpern und dem Schweregrad der Azidose, ähneln sich jedoch in der Behandlung. Die Hypoglykämie ist dagegen der limitierende Faktor beim Erreichen ehrgeiziger Glukoseziele. Der vorliegende Beitrag beschreibt Klinik, Diagnostik und Notfallmanagement dieser Stoffwechselentgleisungen.
Literatur
1.
Zurück zum Zitat Basu A, Close CF, Jenkins D et al (1993) Persisting mortality in diabetic ketoacidosis. Diabet Med 10:282–284CrossRefPubMed Basu A, Close CF, Jenkins D et al (1993) Persisting mortality in diabetic ketoacidosis. Diabet Med 10:282–284CrossRefPubMed
2.
Zurück zum Zitat Bergenstal RM, Welsh JB, Shin JJ (2013) Threshold insulin-pump interruption to reduce hypoglycemia. N Engl J Med 369:1474CrossRefPubMed Bergenstal RM, Welsh JB, Shin JJ (2013) Threshold insulin-pump interruption to reduce hypoglycemia. N Engl J Med 369:1474CrossRefPubMed
3.
Zurück zum Zitat Böhm B. O. DM, Fritsche A., Füchtenbusch M., Gölz S., Martin S. (2011) S3-Leitlinie Therapie des Typ-1-Diabetes. Böhm B. O. DM, Fritsche A., Füchtenbusch M., Gölz S., Martin S. (2011) S3-Leitlinie Therapie des Typ-1-Diabetes.
4.
Zurück zum Zitat Brunelle BL, Llewelyn J, Anderson JH Jr. et al (1998) Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 21:1726–1731CrossRefPubMed Brunelle BL, Llewelyn J, Anderson JH Jr. et al (1998) Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 21:1726–1731CrossRefPubMed
5.
Zurück zum Zitat Chua HR, Venkatesh B, Stachowski E et al (2012) Plasma-Lyte 148 vs 0.9 % saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care 27:138–145CrossRefPubMed Chua HR, Venkatesh B, Stachowski E et al (2012) Plasma-Lyte 148 vs 0.9 % saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care 27:138–145CrossRefPubMed
6.
Zurück zum Zitat Cranston I, Lomas J, Maran A et al (1994) Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283–287CrossRefPubMed Cranston I, Lomas J, Maran A et al (1994) Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283–287CrossRefPubMed
7.
Zurück zum Zitat Cryer PE (2013) Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 369:362–372CrossRefPubMed Cryer PE (2013) Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 369:362–372CrossRefPubMed
8.
Zurück zum Zitat Cryer PE (2014) Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes 63:2188–2195CrossRefPubMed Cryer PE (2014) Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes 63:2188–2195CrossRefPubMed
9.
Zurück zum Zitat Cryer PE, Axelrod L, Grossman AB et al (2009) Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94:709–728CrossRefPubMed Cryer PE, Axelrod L, Grossman AB et al (2009) Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94:709–728CrossRefPubMed
10.
Zurück zum Zitat Dhatariya K (2016) Blood ketones: measurement, interpretation, limitations, and utility in the management of diabetic Ketoacidosis. Rev Diabet Stud 13:217–225CrossRefPubMed Dhatariya K (2016) Blood ketones: measurement, interpretation, limitations, and utility in the management of diabetic Ketoacidosis. Rev Diabet Stud 13:217–225CrossRefPubMed
11.
Zurück zum Zitat Dhatariya KK, Vellanki P (2017) Treatment of diabetic Ketoacidosis (DKA)/hyperglycemic Hyperosmolar state (HHS): novel advances in the management of hyperglycemic crises (UK versus USA). Curr Diab Rep 17:33CrossRefPubMedPubMedCentral Dhatariya KK, Vellanki P (2017) Treatment of diabetic Ketoacidosis (DKA)/hyperglycemic Hyperosmolar state (HHS): novel advances in the management of hyperglycemic crises (UK versus USA). Curr Diab Rep 17:33CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129–139CrossRefPubMed Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129–139CrossRefPubMed
13.
Zurück zum Zitat Fralick M, Schneeweiss S, Patorno E (2017) Risk of diabetic Ketoacidosis after initiation of an SGLT2 inhibitor. N Engl J Med 376:2300–2302CrossRefPubMed Fralick M, Schneeweiss S, Patorno E (2017) Risk of diabetic Ketoacidosis after initiation of an SGLT2 inhibitor. N Engl J Med 376:2300–2302CrossRefPubMed
14.
Zurück zum Zitat Gerstein HC, Miller ME, Byington RP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559CrossRefPubMed Gerstein HC, Miller ME, Byington RP et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559CrossRefPubMed
15.
Zurück zum Zitat Guo RX, Yang LZ, Li LX et al (2008) Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J Obstet Gynaecol Res 34:324–330CrossRefPubMed Guo RX, Yang LZ, Li LX et al (2008) Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J Obstet Gynaecol Res 34:324–330CrossRefPubMed
16.
Zurück zum Zitat Kamel KS, Halperin ML (2015) Acid-base problems in diabetic ketoacidosis. N Engl J Med 372:1969–1970CrossRefPubMed Kamel KS, Halperin ML (2015) Acid-base problems in diabetic ketoacidosis. N Engl J Med 372:1969–1970CrossRefPubMed
17.
Zurück zum Zitat Khunti K, Alsifri S, Aronson R et al (2016) Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab 18:907–915CrossRefPubMedPubMedCentral Khunti K, Alsifri S, Aronson R et al (2016) Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab 18:907–915CrossRefPubMedPubMedCentral
18.
19.
Zurück zum Zitat Kitabchi AE, Umpierrez GE, Murphy MB et al (2001) Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131–153CrossRefPubMed Kitabchi AE, Umpierrez GE, Murphy MB et al (2001) Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131–153CrossRefPubMed
20.
Zurück zum Zitat Lipska KJ, Ross JS, Wang Y et al (2014) National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 174:1116–1124CrossRefPubMedPubMedCentral Lipska KJ, Ross JS, Wang Y et al (2014) National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 174:1116–1124CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Malone ML, Gennis V, Goodwin JS (1992) Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc 40:1100–1104CrossRefPubMed Malone ML, Gennis V, Goodwin JS (1992) Characteristics of diabetic ketoacidosis in older versus younger adults. J Am Geriatr Soc 40:1100–1104CrossRefPubMed
22.
Zurück zum Zitat Murad MH, Coto-Yglesias F, Wang AT et al (2009) Clinical review: drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 94:741–745CrossRefPubMed Murad MH, Coto-Yglesias F, Wang AT et al (2009) Clinical review: drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab 94:741–745CrossRefPubMed
23.
Zurück zum Zitat Neu A, Hofer SE, Karges B et al (2009) Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions. Diabetes Care 32:1647–1648CrossRefPubMedPubMedCentral Neu A, Hofer SE, Karges B et al (2009) Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions. Diabetes Care 32:1647–1648CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Nordin C (2010) The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence. Diabetologia 53:1552–1561CrossRefPubMed Nordin C (2010) The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence. Diabetologia 53:1552–1561CrossRefPubMed
25.
Zurück zum Zitat Nyenwe EA, Kitabchi AE (2016) The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism 65:507–521CrossRefPubMed Nyenwe EA, Kitabchi AE (2016) The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metabolism 65:507–521CrossRefPubMed
26.
Zurück zum Zitat Pasquel FJ, Umpierrez GE (2014) Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care 37:3124–3131CrossRefPubMedPubMedCentral Pasquel FJ, Umpierrez GE (2014) Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care 37:3124–3131CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRefPubMed Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572CrossRefPubMed
28.
Zurück zum Zitat Peters AL, Buschur EO, Buse JB et al (2015) Euglycemic diabetic Ketoacidosis: a potential complication of treatment with sodium-glucose Cotransporter 2 inhibition. Diabetes Care 38:1687–1693CrossRefPubMedPubMedCentral Peters AL, Buschur EO, Buse JB et al (2015) Euglycemic diabetic Ketoacidosis: a potential complication of treatment with sodium-glucose Cotransporter 2 inhibition. Diabetes Care 38:1687–1693CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Pfortmueller CA, Wiemann C, Funk GC et al (2014) Hypoglycemia is associated with increased mortality in patients with acute decompensated liver cirrhosis. J Crit Care 29(316):e317–312 Pfortmueller CA, Wiemann C, Funk GC et al (2014) Hypoglycemia is associated with increased mortality in patients with acute decompensated liver cirrhosis. J Crit Care 29(316):e317–312
30.
Zurück zum Zitat Ratner RE, Gough SC, Mathieu C et al (2013) Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes Obes Metab 15:175–184CrossRefPubMed Ratner RE, Gough SC, Mathieu C et al (2013) Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes Obes Metab 15:175–184CrossRefPubMed
31.
Zurück zum Zitat Razavi Nematollahi L, Kitabchi AE, Stentz FB et al (2009) Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 58:443–448CrossRefPubMed Razavi Nematollahi L, Kitabchi AE, Stentz FB et al (2009) Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 58:443–448CrossRefPubMed
32.
Zurück zum Zitat Ritzel R, Roussel R, Bolli GB et al (2015) Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Diabetes Obes Metab 17:859–867CrossRefPubMedPubMedCentral Ritzel R, Roussel R, Bolli GB et al (2015) Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Diabetes Obes Metab 17:859–867CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Schwartz NS, Clutter WE, Shah SD et al (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777–781CrossRefPubMedPubMedCentral Schwartz NS, Clutter WE, Shah SD et al (1987) Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777–781CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Seaquist ER, Anderson J, Childs B et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36:1384–1395CrossRefPubMedPubMedCentral Seaquist ER, Anderson J, Childs B et al (2013) Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36:1384–1395CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Sporer KA, Ernst AA, Conte R et al (1992) The incidence of ethanol-induced hypoglycemia. Am J Emerg Med 10:403–405CrossRefPubMed Sporer KA, Ernst AA, Conte R et al (1992) The incidence of ethanol-induced hypoglycemia. Am J Emerg Med 10:403–405CrossRefPubMed
37.
Zurück zum Zitat Taboulet P, Haas L, Porcher R et al (2004) Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of ketoacidosis in the emergency department setting. Eur J Emerg Med 11:251–258CrossRefPubMed Taboulet P, Haas L, Porcher R et al (2004) Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of ketoacidosis in the emergency department setting. Eur J Emerg Med 11:251–258CrossRefPubMed
38.
Zurück zum Zitat Tran TTT, Pease A, Wood AJ et al (2017) Review of evidence for adult diabetic Ketoacidosis management protocols. Front Endocrinol (Lausanne) 8:106CrossRef Tran TTT, Pease A, Wood AJ et al (2017) Review of evidence for adult diabetic Ketoacidosis management protocols. Front Endocrinol (Lausanne) 8:106CrossRef
39.
Zurück zum Zitat Tsujimoto T, Yamamoto-Honda R, Kajio H et al (2014) Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 37:217–225CrossRefPubMed Tsujimoto T, Yamamoto-Honda R, Kajio H et al (2014) Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 37:217–225CrossRefPubMed
Metadaten
Titel
Diabetologische Notfälle
Hypoglykämie, ketoazidotisches und hyperglykämisches Koma
verfasst von
Dr. med. H. Kalscheuer
G. Serfling
S. Schmid
H. Lehnert
Publikationsdatum
28.08.2017
Verlag
Springer Medizin
Erschienen in
Die Innere Medizin / Ausgabe 10/2017
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-017-0317-x

Weitere Artikel der Ausgabe 10/2017

Der Internist 10/2017 Zur Ausgabe

Kongresse des BDI

Kongresse des BDI

Mitteilungen des BDI

Mitteilungen des BDI

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft.